Evidence map›Paper›PMID 38632379›Full record

ReviewNature protocols2024

Reprogramming fibroblast into human iBlastoids.

Jia Ping Tan, Xiaodong Liu, Jose M Polo

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature protocols, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 3 countries.

Jia Ping TanDepartment of Anatomy and Developmental Biology, Monash University, Clayton, Victoria, Australia.
Xiaodong LiuSchool of Life Sciences, Westlake University, Hangzhou, Zhejiang, China. liuxiaodong@westlake.edu.cn.ORCID 0000-0002-9315-3406
Jose M PoloDepartment of Anatomy and Developmental Biology, Monash University, Clayton, Victoria, Australia. Jose.Polo@monash.edu.ORCID 0000-0002-2531-778X
Australian Regenerative Medicine Institute · AUDiscovery Institute · USWestlake University · CN

Funding

Department of Health | National Health and Medical Research Council (NHMRC) APP1104560Department of Health | National Health and Medical Research Council (NHMRC) APP2004627Department of Health | National Health and Medical Research Council (NHMRC) Sinergy 2019251
6 · The paper itself

Abstract

The study of early human embryogenesis has relied on the use of blastocysts donated to research or simple stem cell culture systems such as pluripotent and trophoblast stem cells, which have been seminal in shedding light on many key developmental processes. However, simple culture systems lack the necessary complexity to adequately model the spatiotemporal, cellular and molecular dynamics occurring during the early phases of embryonic development. As such, an in vitro model of the human blastocyst is advantageous in many aspects to decipher human embryogenesis. Here we describe a step-by-step protocol for the generation of induced blastoids (iBlastoids), an in vitro integrated model of the human blastocyst derived via somatic reprogramming. This protocol details the workflow for reprogramming of human dermal fibroblasts and subsequent generation of iBlastoids using the reprogramming intermediates, which together takes ~27 days (21 days for reprogramming and 6 days for iBlastoid generation). We also discuss several characterization/functional assays that can be used on the iBlastoids. We believe that a person trained in cell culture with ~1 year of experience with human somatic cell and reprogramming/cell differentiation assays would be able to perform this protocol. In short, the iBlastoids present an alternative tool as a model to the blastocyst to facilitate the scientific community in the exploration of early human development.

Indexed as

Cellular ReprogrammingFibroblastsBlastocystCell Culture TechniquesCell DifferentiationCells, CulturedHumans

Identifiers

PMID38632379
OpenAlexW4394879549

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.